POC脂質検査市場：成分、適応症、エンドユーザー別-2025～2030年の世界予測

POC脂質検査市場は、2023年に3億1,541万米ドルと評価され、2024年には3億3,333万米ドルに達すると予測され、CAGR 6.18％で成長し、2030年には4億8,015万米ドルに達すると予測されています。

POC（ポイントオブケア）脂質検査は、より広範な診断の場における新たなセグメントであり、クリニックや家庭環境といった従来の検査室以外の場所でも即座に脂質プロファイル分析を提供することに重点を置いています。この迅速な検査パラダイムは、心血管疾患や糖尿病など、脂質レベルの継続的なモニタリングを必要とする疾患の早期発見という重要なニーズに応えるものです。POC脂質検査の有用性は、迅速で信頼性の高い結果を提供する能力にあり、医療プロバイダーがタイムリーな決定を下し、患者のケアを個別化することを可能にします。急速な都市化と医療意識の高まりは、臨床検査室から在宅医療まで、さまざまな環境での需要を促進し、最終用途の範囲を大きく広げています。主要成長要因としては、慢性疾患の増加、ポータブル検査機器の技術進歩、迅速で便利な診断に対する消費者の嗜好などが挙げられます。しかし、市場は、規制上の課題、コストの制約、精度に関する問題など、より広範な導入に影響を与えかねない制約に直面しています。このようなハードルにもかかわらず、ナノ技術とバイオセンサーにおける最近の進歩は、技術革新のための肥沃な土壌を提供し、精度の向上とコスト削減の機会を提供することで、市場範囲を拡大しています。企業は、次世代POCデバイスに焦点を当てた研究開発に投資し、POC検査の利点について患者を教育するために医療プロバイダーとの協力を促進することで、こうした機会を捉えることができます。市場の競争は激しく、複数の企業が製品ラインの多様化と革新を通じて市場シェアの獲得に努めています。市場が発展するにつれて、人工知能とデータ分析を統合して予測診断を強化することが重要な差別化要因となる可能性があります。まとめると、課題は存在するもの、技術の進歩、法規制の遵守、戦略的パートナーシップに注力することで、POC脂質検査市場の持続的成長が可能になり、探求と革新の機が熟したセグメントとなります。

市場力学：急速に進化するPOC脂質検査市場の主要市場洞察を公開

POC脂質検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 全世界における心血管疾患の有病率の増加
  • 民間と公的部門による医療への投資増加
• 市場抑制要因
  • POC脂質検査製品の製造に伴う高コスト
• 市場機会
  • 医療産業におけるポイントオブケア脂質検査製品開発のための継続的な技術革新
  • 診断センターの増加による医療と検査へのアクセスの向上
• 市場課題
  • POC脂質検査に関連する品質への懸念

ポーターのファイブフォース：POC脂質検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：POC脂質検査市場における外部からの影響の把握

外部マクロ環境要因は、POC脂質検査市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：POC脂質検査市場における競合情勢の把握

POC脂質検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：POC脂質検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、POC脂質検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：POC脂質検査市場における成功への道筋を描く

POC脂質検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で心血管疾患の罹患率が増加
    • 民間と公共部門による医療への投資増加
  • 抑制要因
    • POC脂質検査製品の製造に関連する高コスト
  • 機会
    • 医療産業におけるポイントオブケア脂質検査製品の開発に向けた継続的なイノベーション
    • 診断センターの増加による医療と検査へのアクセスの向上
  • 課題
    • POC脂質検査に関連する品質に関する懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 POC脂質検査市場：コンポーネント別

• イントロダクション
• 機器
• ソフトウェア

第7章 POC脂質検査市場：適応症別

• イントロダクション
• 心血管疾患
• 高コレステロール血症
• 高脂血症
• タンジール病

第8章 POC脂質検査市場：エンドユーザー別

• イントロダクション
• 診断センター
• 病院・クリニック

第9章 南北アメリカのPOC脂質検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋のPOC脂質検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのPOC脂質検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abaxis, Inc. by Zoetis Inc.
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• bioMerieux SA
• Callegari Srl
• Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
• Danaher Corporation
• EKF Diagnostics Holdings plc
• F. Hoffmann-La Roche Ltd.
• General Life BIoTechnology Co., Ltd.
• Helena Laboratories Corporation
• Menarini Group
• Nova Biomedical
• Quidel Corporation
• SD Biosensor, Inc.
• Sekisui Medical Co., Ltd.
• Siemens AG
• Sienco, Inc.
• Sinocare Inc.
• Thermo Fisher Scientific Inc.
• Trinity BIoTech PLC
• VivaChek BIoTech（Hangzhou）Co., Ltd.
• Werfen, S.A.

LIST OF FIGURES

• FIGURE 1. POC LIPID TESTING MARKET RESEARCH PROCESS
• FIGURE 2. POC LIPID TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL POC LIPID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL POC LIPID TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL POC LIPID TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL POC LIPID TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. POC LIPID TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. POC LIPID TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. POC LIPID TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL POC LIPID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL POC LIPID TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. POC LIPID TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL POC LIPID TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL POC LIPID TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL POC LIPID TESTING MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL POC LIPID TESTING MARKET SIZE, BY HYPERCHOLESTEROLEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL POC LIPID TESTING MARKET SIZE, BY HYPERLIPIDAEMIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL POC LIPID TESTING MARKET SIZE, BY TANGIER DISEASE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL POC LIPID TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL POC LIPID TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES POC LIPID TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA POC LIPID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM POC LIPID TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. POC LIPID TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. POC LIPID TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The POC Lipid Testing Market was valued at USD 315.41 million in 2023, expected to reach USD 333.33 million in 2024, and is projected to grow at a CAGR of 6.18%, to USD 480.15 million by 2030.

Point-of-Care (POC) Lipid Testing is an emerging segment within the broader diagnostics landscape, focused on providing immediate lipid profile analysis outside traditional laboratory settings, such as clinics and home environments. This rapid testing paradigm serves the critical need for early detection of conditions like cardiovascular diseases and diabetes, which require continual monitoring of lipid levels. The utility of POC lipid testing lies in its ability to offer swift, reliable results, enabling healthcare providers to make timely decisions and personalize patient care. Rapid urbanization and rising healthcare awareness are propelling demands across varied settings, from clinical laboratories to home healthcare, extending the end-use scope significantly. Key growth influencers include increasing incidences of chronic diseases, technological advancements in portable testing devices, and consumer preference for quick, convenient diagnostics. However, the market faces limitations like regulatory challenges, cost constraints, and issues concerning accuracy that could impact wider adoption. Despite these hurdles, recent advances in nanotechnology and biosensors present fertile ground for innovation, offering opportunities to enhance accuracy and reduce costs, thus expanding market reach. Companies can capture these opportunities by investing in R&D focused on next-generation POC devices and fostering collaborations with healthcare providers to educate patients about the benefits of POC testing. The nature of the market is competitive, with several players striving for market share through diversification and innovation in product lines. As the market evolves, integrating artificial intelligence and data analytics to enhance predictive diagnostics can be key differentiators. In summary, while challenges exist, focusing on technological advancements, regulatory compliance, and strategic partnerships can enable sustained growth in the POC lipid testing market, making it an area ripe for exploration and innovation.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving POC Lipid Testing Market

The POC Lipid Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in prevalence of cardiovascular disease across the globe
  • Rising investment on healthcare by private and public sector
• Market Restraints
  • High cost associated with the production of POC lipid testing products
• Market Opportunities
  • Ongoing innovation in medical industry for developing point of care lipid test products
  • Improving accessibility to healthcare and tests with rise in number of diagnostic centers
• Market Challenges
  • Quality concerns associated with POC lipid testing

Porter's Five Forces: A Strategic Tool for Navigating the POC Lipid Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the POC Lipid Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the POC Lipid Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the POC Lipid Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the POC Lipid Testing Market

A detailed market share analysis in the POC Lipid Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the POC Lipid Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the POC Lipid Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the POC Lipid Testing Market

A strategic analysis of the POC Lipid Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the POC Lipid Testing Market, highlighting leading vendors and their innovative profiles. These include Abaxis, Inc. by Zoetis Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., bioMerieux SA, Callegari Srl, Chembio Diagnostic Systems, Inc. by BIOSYNEX SA, Danaher Corporation, EKF Diagnostics Holdings plc, F. Hoffmann-La Roche Ltd., General Life Biotechnology Co., Ltd., Helena Laboratories Corporation, Menarini Group, Nova Biomedical, Quidel Corporation, SD Biosensor, Inc., Sekisui Medical Co., Ltd., Siemens AG, Sienco, Inc., Sinocare Inc., Thermo Fisher Scientific Inc., Trinity Biotech PLC, VivaChek Biotech (Hangzhou) Co., Ltd., and Werfen, S.A..

Market Segmentation & Coverage

This research report categorizes the POC Lipid Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Instruments and Software.
• Based on Indication, market is studied across Cardiovascular Disease, Hypercholesterolemia, Hyperlipidaemia, and Tangier Disease.
• Based on End-User, market is studied across Diagnostic Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in prevalence of cardiovascular disease across the globe
    • 5.1.1.2. Rising investment on healthcare by private and public sector
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the production of POC lipid testing products
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing innovation in medical industry for developing point of care lipid test products
    • 5.1.3.2. Improving accessibility to healthcare and tests with rise in number of diagnostic centers
  • 5.1.4. Challenges
    • 5.1.4.1. Quality concerns associated with POC lipid testing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. POC Lipid Testing Market, by Component

• 6.1. Introduction
• 6.2. Instruments
• 6.3. Software

7. POC Lipid Testing Market, by Indication

• 7.1. Introduction
• 7.2. Cardiovascular Disease
• 7.3. Hypercholesterolemia
• 7.4. Hyperlipidaemia
• 7.5. Tangier Disease

8. POC Lipid Testing Market, by End-User

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Hospitals & Clinics

9. Americas POC Lipid Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific POC Lipid Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa POC Lipid Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abaxis, Inc. by Zoetis Inc.
• 2. Abbott Laboratories
• 3. Bio-Rad Laboratories, Inc.
• 4. bioMerieux SA
• 5. Callegari Srl
• 6. Chembio Diagnostic Systems, Inc. by BIOSYNEX SA
• 7. Danaher Corporation
• 8. EKF Diagnostics Holdings plc
• 9. F. Hoffmann-La Roche Ltd.
• 10. General Life Biotechnology Co., Ltd.
• 11. Helena Laboratories Corporation
• 12. Menarini Group
• 13. Nova Biomedical
• 14. Quidel Corporation
• 15. SD Biosensor, Inc.
• 16. Sekisui Medical Co., Ltd.
• 17. Siemens AG
• 18. Sienco, Inc.
• 19. Sinocare Inc.
• 20. Thermo Fisher Scientific Inc.
• 21. Trinity Biotech PLC
• 22. VivaChek Biotech (Hangzhou) Co., Ltd.
• 23. Werfen, S.A.